Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2022 Earnings Call Transcript May 11, 2023
Takeda Pharmaceutical Company Limited reports earnings inline with expectations. Reported EPS is $0.39 EPS, expectations were $0.39.
Christopher O’Reilly: Thank you very much for joining FY 2022 earnings announcement of Takeda. I will serve as MC, Head of IR. My name is O’Reilly. [Operator Instructions] Before starting, I would like to remind everyone that we will be discussing forward-looking...
